These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 7851336)
1. ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment. Tosteson AN; Weinstein MC; Wittenberg J; Begg CB Environ Health Perspect; 1994 Nov; 102 Suppl 8(Suppl 8):73-8. PubMed ID: 7851336 [TBL] [Abstract][Full Text] [Related]
2. A general regression methodology for ROC curve estimation. Tosteson AN; Begg CB Med Decis Making; 1988; 8(3):204-15. PubMed ID: 3294553 [TBL] [Abstract][Full Text] [Related]
3. Bayesian analysis of ROC curves using Markov-chain Monte Carlo methods. Peng F; Hall WJ Med Decis Making; 1996; 16(4):404-11. PubMed ID: 8912302 [TBL] [Abstract][Full Text] [Related]
4. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Motosugi U; Ichikawa T; Morisaka H; Sou H; Muhi A; Kimura K; Sano K; Araki T Radiology; 2011 Aug; 260(2):446-53. PubMed ID: 21693662 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging, computed tomography, and radionuclide scintigraphy in detection of liver metastases. Bronskill MJ; Henkelman RM; Poon PY; Ege GN; Dunlap HJ; Ho CS; Goldfinger M; Taylor BR; Stone RM; Sutcliffe SB Can Assoc Radiol J; 1988 Mar; 39(1):3-9. PubMed ID: 2966165 [TBL] [Abstract][Full Text] [Related]
6. Receiver operator characteristic (ROC) analysis without truth. Henkelman RM; Kay I; Bronskill MJ Med Decis Making; 1990; 10(1):24-9. PubMed ID: 2325524 [TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889 [TBL] [Abstract][Full Text] [Related]
8. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI. Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103 [TBL] [Abstract][Full Text] [Related]
9. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Senéterre E; Taourel P; Bouvier Y; Pradel J; Van Beers B; Daures JP; Pringot J; Mathieu D; Bruel JM Radiology; 1996 Sep; 200(3):785-92. PubMed ID: 8756932 [TBL] [Abstract][Full Text] [Related]
10. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131 [TBL] [Abstract][Full Text] [Related]
11. Small area estimation of receiver operating characteristic curves for ordinal data under stochastic ordering. Jang EJ; Nandram B; Ko Y; Kim DH Stat Med; 2020 May; 39(10):1514-1528. PubMed ID: 32017182 [TBL] [Abstract][Full Text] [Related]
12. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. Valls C; Lopez E; Gumà A; Gil M; Sanchez A; Andía E; Serra J; Moreno V; Figueras J AJR Am J Roentgenol; 1998 May; 170(5):1341-7. PubMed ID: 9574613 [TBL] [Abstract][Full Text] [Related]
14. Staging of advanced ovarian cancer: comparison of imaging modalities--report from the Radiological Diagnostic Oncology Group. Tempany CM; Zou KH; Silverman SG; Brown DL; Kurtz AB; McNeil BJ Radiology; 2000 Jun; 215(3):761-7. PubMed ID: 10831697 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases. Beiderwellen K; Geraldo L; Ruhlmann V; Heusch P; Gomez B; Nensa F; Umutlu L; Lauenstein TC PLoS One; 2015; 10(9):e0137285. PubMed ID: 26335246 [TBL] [Abstract][Full Text] [Related]
16. Ordinal regression methodology for ROC curves derived from correlated data. Toledano AY; Gatsonis C Stat Med; 1996 Aug; 15(16):1807-26. PubMed ID: 8870162 [TBL] [Abstract][Full Text] [Related]
17. Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. Alderson PO; Adams DF; McNeil BJ; Sanders R; Siegelman SS; Finberg HJ; Hessel SJ; Abrams HL Radiology; 1983 Oct; 149(1):225-30. PubMed ID: 6611929 [TBL] [Abstract][Full Text] [Related]
18. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Holzapfel K; Reiser-Erkan C; Fingerle AA; Erkan M; Eiber MJ; Rummeny EJ; Friess H; Kleeff J; Gaa J Abdom Imaging; 2011 Apr; 36(2):179-84. PubMed ID: 20563868 [TBL] [Abstract][Full Text] [Related]
19. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]